Exploring the utility of Deep Red Anthraquinone 5 for digital staining of ex vivo confocal micrographs of optically sectioned skin.

DRAQ5 EVCM Mohs acridine orange confocal microscopy tissue fixture

Journal

Journal of biophotonics
ISSN: 1864-0648
Titre abrégé: J Biophotonics
Pays: Germany
ID NLM: 101318567

Informations de publication

Date de publication:
04 2021
Historique:
revised: 10 12 2020
received: 29 05 2020
accepted: 11 12 2020
pubmed: 15 12 2020
medline: 13 7 2021
entrez: 14 12 2020
Statut: ppublish

Résumé

We investigated the utility of the fluorescent dye Deep Red Anthraquinone 5 (DRAQ5) for digital staining of optically sectioned skin in comparison to acridine orange (AO). Eight fresh-frozen thawed Mohs discard tissue specimens were stained with AO and DRAQ5, and imaged using an ex vivo confocal microscope at three wavelengths (488 nm and 638 nm for fluorescence, 785 nm for reflectance). Images were overlaid (AO + Reflectance, DRAQ5 + Reflectance), digitally stained, and evaluated by three investigators for perceived image quality (PIQ) and histopathological feature identification. In addition to nuclear staining, AO seemed to stain dermal fibers in a subset of cases in digitally stained images, while DRAQ5 staining was more specific to nuclei. Blinded evaluation showed substantial agreement, favoring DRAQ5 for PIQ (82%, Cl 75%-90%, Gwet's AC 0.74) and for visualization of histopathological features in (81%, Cl 73%-89%, Gwet's AC 0.67), supporting its use in digital staining of multimodal confocal micrographs of skin.

Identifiants

pubmed: 33314673
doi: 10.1002/jbio.202000207
pmc: PMC8274380
mid: NIHMS1717419
doi:

Substances chimiques

Anthraquinones 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202000207

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NIBIB NIH HHS
ID : R01 EB020029
Pays : United States
Organisme : NIBIB NIH HHS
ID : R01EB020029
Pays : United States

Informations de copyright

© 2020 Wiley-VCH GmbH.

Références

Arch Pathol Lab Med. 2018 Mar;142(3):396-401
pubmed: 29266968
Curr Protoc Cytom. 2012 Jul;Chapter 9:Unit 9.39
pubmed: 22752953
PLoS One. 2016 Oct 27;11(10):e0165530
pubmed: 27788264
Methods Enzymol. 2014;537:17-30
pubmed: 24480339
Actas Dermosifiliogr (Engl Ed). 2020 Apr;111(3):236-242
pubmed: 31959303
J Biomed Opt. 2012 Jun;17(6):066008
pubmed: 22734764
J Am Acad Dermatol. 2019 Apr;80(4):e91-e92
pubmed: 30578817
Methods Enzymol. 2014;537:47-73
pubmed: 24480341
JAMA Dermatol. 2016 Dec 1;152(12):1335-1341
pubmed: 27603676
Br J Dermatol. 2020 Dec;183(6):1011-1025
pubmed: 32134506
BJU Int. 2019 Sep;124(3):469-476
pubmed: 30908852
Brain Pathol. 2013 Jan;23(1):73-81
pubmed: 22882328
JAMA Netw Open. 2020 Mar 2;3(3):e200476
pubmed: 32134465
Lakartidningen. 2017 Nov 13;114:
pubmed: 29292918
J Biomed Opt. 2017 Feb 1;22(2):24002
pubmed: 28199474
J Biomed Opt. 2011 Jul;16(7):076008
pubmed: 21806269
J Biomed Opt. 2017 Mar 1;22(3):34002
pubmed: 28327961
Lasers Surg Med. 2007 Oct;39(9):696-705
pubmed: 17960751
Adipocyte. 2017 Apr 3;6(2):112-123
pubmed: 28453382
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):1496-1499
pubmed: 31732988
BMC Med Res Methodol. 2013 Apr 29;13:61
pubmed: 23627889
J Biomed Opt. 2008 Sep-Oct;13(5):054001
pubmed: 19021381
Front Oncol. 2019 Sep 24;9:925
pubmed: 31612102
Annu Rev Med. 2018 Jan 29;69:263-276
pubmed: 28877002
Arch Pathol Lab Med. 2019 Mar;143(3):305-313
pubmed: 30376375
Virchows Arch. 2020 Apr;476(4):511-520
pubmed: 31907606
J Cell Sci. 2016 Dec 15;129(24):4622-4632
pubmed: 27875278
Skin Res Technol. 2019 Jul;25(4):589-591
pubmed: 30861221
Arch Neurol. 1980 Oct;37(10):641-4
pubmed: 6158935
J Photochem Photobiol B. 2016 Jun;159:169-78
pubmed: 27077554
J Biomed Opt. 2012 Jun;17(6):066018
pubmed: 22734774
J Biomed Opt. 2007 May-Jun;12(3):034027
pubmed: 17614735
BJU Int. 2020 Apr;125(4):487-489
pubmed: 31971342
J Biomed Opt. 2009 May-Jun;14(3):034050
pubmed: 19566342
J Nephrol. 2021 Jun;34(3):689-697
pubmed: 32876939
J Biomed Opt. 2011 May;16(5):050504
pubmed: 21639560

Auteurs

Vinzent Kevin Ortner (VK)

Department of Dermatology, Copenhagen University Hospital, Frederiskberg, Denmark.

Aditi Sahu (A)

Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Miguel Cordova (M)

Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Kivanc Kose (K)

Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Saud Aleissa (S)

Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Christi Alessi-Fox (C)

Caliber Imaging and Diagnostics Inc., Rochester, New York, USA.

Merete Haedersdal (M)

Department of Dermatology, Copenhagen University Hospital, Frederiskberg, Denmark.

Milind Rajadhyaksha (M)

Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Anthony Mario Rossi (AM)

Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH